This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26, 2027
Hynes Convention CenterBoston, MA

William Fang
Vice President of Oligonucleotide and Peptide Development at WuXi TIDES
Speaker

Profile

William Fang is the Vice President, Head of the Oligo/Peptide Development at WuXi TIDES. He has held various roles for over ten years with WuXi AppTec and has extensive experience in peptide R&D and manufacturing. Previously he worked at Zhejiang Runxin Pharmtech and Polypeptide labs. William received his bachelor’s degree from Beijing Medical University, his Master’s degree from Creighton

Agenda Sessions

  • Overcoming Scale-Up Barriers: Ensuring Robust CMC for Next-Gen Peptide and Oligonucleotide Drugs

    7:45am